Ileal FXR-FGF15/19 signaling activation improves skeletal muscle loss in aged mice
- PMID: 35026209
- DOI: 10.1016/j.mad.2022.111630
Ileal FXR-FGF15/19 signaling activation improves skeletal muscle loss in aged mice
Abstract
Sarcopenia is the age-related decrease in skeletal muscle mass, and current therapies for this disease are ineffective. We previously showed that ileal farnesoid X receptor (FXR)-fibroblast growth factor 15/19 (FGF15/19) signaling acts as a regulator of gut microbiota to mediate host skeletal muscle. However, the therapeutic potential of this pathway for sarcopenia is unknown. This study showed that ileal FXR-FGF15/19 signaling was downregulated in older men and aged male mice due to changes in the gut microbiota and microbial bile acid metabolism during aging. In addition, the intestine-specific FXR agonist fexaramine increased skeletal muscle mass and improve muscle performance in aged mice. Ileal FXR activation increased skeletal muscle protein synthesis in a FGF15/19-dependent way, indicating that ileal FXR-FGF15/19 signaling is a potential therapeutic target for sarcopenia.
Keywords: Bile acid; FGF15/19; FXR; Fexaramine; Skeletal muscle.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling.Ann Med. 2021 Dec;53(1):508-522. doi: 10.1080/07853890.2021.1900593. Ann Med. 2021. PMID: 33783283 Free PMC article.
-
Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.Inflamm Bowel Dis. 2016 Oct;22(10):2382-9. doi: 10.1097/MIB.0000000000000879. Inflamm Bowel Dis. 2016. PMID: 27580383
-
Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.Am J Physiol Gastrointest Liver Physiol. 2019 Mar 1;316(3):G404-G411. doi: 10.1152/ajpgi.00188.2018. Epub 2019 Jan 17. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30653340
-
Bile Acids as Hormones: The FXR-FGF15/19 Pathway.Dig Dis. 2015;33(3):327-31. doi: 10.1159/000371670. Epub 2015 May 27. Dig Dis. 2015. PMID: 26045265 Free PMC article. Review.
-
FXR an emerging therapeutic target for the treatment of atherosclerosis.J Cell Mol Med. 2010 Jan;14(1-2):79-92. doi: 10.1111/j.1582-4934.2009.00997.x. J Cell Mol Med. 2010. PMID: 20041971 Free PMC article. Review.
Cited by
-
The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis.Orphanet J Rare Dis. 2023 Sep 5;18(1):273. doi: 10.1186/s13023-023-02885-1. Orphanet J Rare Dis. 2023. PMID: 37670327 Free PMC article.
-
Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1/2 signalling pathway.Stem Cell Res Ther. 2023 Aug 4;14(1):195. doi: 10.1186/s13287-023-03418-0. Stem Cell Res Ther. 2023. PMID: 37542297 Free PMC article.
-
Gut microbiota in muscular atrophy development, progression, and treatment: New therapeutic targets and opportunities.Innovation (Camb). 2023 Jul 10;4(5):100479. doi: 10.1016/j.xinn.2023.100479. eCollection 2023 Sep 11. Innovation (Camb). 2023. PMID: 37539440 Free PMC article. Review.
-
Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family.Mil Med Res. 2024 Jun 21;11(1):40. doi: 10.1186/s40779-024-00544-5. Mil Med Res. 2024. PMID: 38902808 Free PMC article. Review.
-
Role of the Gut Microbiome in Skeletal Muscle Physiology and Pathophysiology.Curr Osteoporos Rep. 2022 Dec;20(6):422-432. doi: 10.1007/s11914-022-00752-9. Epub 2022 Sep 19. Curr Osteoporos Rep. 2022. PMID: 36121571 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources